Health / Medical Topics

    Bafetinib

    An orally active 2-phenylaminopyrimidine derivative with potential antineoplastic activity. INNO-406 specifically binds to and inhibits the Bcr/Abl fusion protein tyrosine kinase, an abnormal enzyme produced by Philadelphia chromosomal translocation associated with chronic myeloid leukemia (CML). Furthermore, this agent also inhibits the Src-family member Lyn tyrosine kinase, upregulated in imatinib-resistant CML cells and in a variety of solid cancer cell types. The inhibitory effect of INNO-406 on these specific tyrosine kinases decreases cellular proliferation and induces apoptosis. A high percentage of CML patients are refractory to imatinib, which sometimes results from point mutations occurring in the kinase domain of the Bcr/Abl fusion product. Due to its dual inhibitory activity, INNO-406 has been shown to overcome this particular drug resistance and to be a potent and effective agent in the treatment of imatinib-resistant CML. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    A test used to detect some types of hearing loss, such as hearing loss caused by injury or tumors that affect nerves…
    Human BAD wild-type allele is located in the vicinity of 11q12.3 and is less than 1 kb in length. This allele, which…
    The function of the pro-apoptotic molecule BAD is regulated by phosphorylation of three sites (ser 112, 136, and 155). Phosphorylation at these…
    The gene plays a role in the positive regulation of cellular apoptosis.
    There are many reasons why you might have bad breath. You can get it if you don't brush and floss…
    Having undesirable or negative qualities.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact